Organization · Venture Capital
HM Venture Partners
HM Venture Partners is a US-based venture capital firm focused on investments in the healthcare sector, particularly in biotechnology and medical technology. The firm manages three funds with a total AUM exceeding $600 million.
Overview
What HM Venture Partners does
What HM Venture Partners is
HM Venture Partners is a US-based venture capital firm focused on investments in the healthcare sector, particularly in biotechnology and medical technology. The firm manages three funds with a total AUM exceeding $600 million.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2018
- Approximate age
- About 8 years
- Structured capabilities
- Funder
- Last reviewed
- April 23, 2026
Official channels
Find HM Venture Partners elsewhere
Open the official website or a supported primary organization account.
Capability profile
HM Venture Partners as a funder
Investment thesis
HM Venture Partners focuses exclusively on healthcare investments, particularly in biotech and medtech, leveraging a strong network from the Mayo Clinic and cross-border opportunities between the US and China.
Focus narrative
The firm invests in healthcare-related companies, focusing on biotech and medtech across all stages. HM Venture Partners engages in diversified healthcare investments globally, with a particular emphasis on leveraging its connections within the Mayo Clinic network to validate and support portfolio companies.
Value beyond capital
HM Venture Partners adds value to its portfolio companies through its extensive network within the Mayo Clinic, providing access to clinical expertise and operational support. The firm also facilitates cross-border opportunities between the US and China, enhancing market access and commercialization strategies for its investments.
Focus and fit
- Stages
- Friends and Family · Angel · Accelerator · Pre-seed · Seed · Seed+ · Series A · Series A+ · Series B · Series B+ · Series C · Series C+ · Series D · Series E · Series F · Growth Equity · Pre-IPO · Ipo
- Regions
- North America · Asia · Global
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 39
- Recorded notable exits
- Arthrosi Therapeutics, Sagimet Biosciences, and GenFleet Therapeutics
Portfolio context
HM Venture Partners has invested in 39 portfolio companies, including notable names such as Arthrosi Therapeutics, Sagimet Biosciences, and GenFleet Therapeutics. The firm also has a presence in China with companies like Hui Every Medical Group. Recent investments include a $20M Series A in Minnesota Medical Technologies Corporation.
Common questions
What to know about HM Venture Partners
Upseed classifies HM Venture Partners under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 23, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.